SCHEMBL19601118

SCHEMBL19601118

COc1ccc(-[n+]2ccc(-c3cc[n+](-c4ccc(C)cc4)cc3OC)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 9/20 0.47
▸ BCHE P06276 5/20 0.47
▸ RAB9A P51151 4/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ RELA Q04206 1/20 0.37
▸ CYP2D6 P10635 2/20 0.36
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2E1 P05181 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C8 P10632 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CYP4B1 P13584 1/20 0.36
▸ CYP2B6 P20813 1/20 0.36
▸ CYP3A5 P20815 1/20 0.36
▸ CYP2A7 P20853 1/20 0.36
▸ CYP3A7 P24462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19601115 0.94 ACHE (0.51) ACHEBCHECYP2D6
SCHEMBL19607291 0.94 ACHE (0.51) ACHEBCHECYP2D6CYP1A1CYP1A2
SCHEMBL19601087 0.87 ACHE (0.44) ACHEBCHERAB9ANPC1KMT2A
SCHEMBL19607343 0.87 ACHE (0.48) ACHEBCHE
SCHEMBL19607240 0.82 ACHE (0.44) ACHEBCHERAB9ANPC1KMT2A
SCHEMBL19601106 0.80 ACHE (0.51) ACHEBCHECYP2D6CYP1A1CYP1A2
SCHEMBL19601122 0.79 HTT (0.50) ACHERAB9ANPC1KMT2AMEN1
SCHEMBL19601114 0.78 ACHE (0.41) ACHEBCHEKMT2AMEN1LMNA
SCHEMBL19601116 0.77 ACHE (0.58) ACHEBCHERAB9ANPC1KMT2A
SCHEMBL17996980 0.76 CA1 (0.50) ACHEBCHERAB9ANPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME CANON KABUSHIKI KAISHA (JP) 2017-11-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170329195-A1 ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME KCNJ2, KCNH3, KCNN2 ACHE 416/4885BCHE 2668/4885RAB9A 2741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback